PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 1 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,000 | 0.0% | 439 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | -70.0% | 439 | 0.0% | 0.00% | – |
Q4 2019 | $10,000 | -23.1% | 439 | -11.1% | 0.00% | – |
Q3 2019 | $13,000 | +18.2% | 494 | +17.1% | 0.00% | – |
Q2 2019 | $11,000 | -26.7% | 422 | 0.0% | 0.00% | – |
Q1 2019 | $15,000 | +114.3% | 422 | +16.9% | 0.00% | – |
Q4 2018 | $7,000 | -30.0% | 361 | 0.0% | 0.00% | – |
Q3 2018 | $10,000 | -28.6% | 361 | 0.0% | 0.00% | – |
Q2 2018 | $14,000 | +16.7% | 361 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 361 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |